Astellas is committed to supporting and maintaining access to medications for patients who have been treated with an Astellas anti-infective. 

The Astellas Access ProgramSM (AAP) was established to provide no-cost stock replacement of injectable medications that have been administered to qualifying uninsured patients. Patients must meet specific criteria to qualify for assistance.

All appropriate paperwork can be found in the Forms and Documents section. For additional questions about the Astellas Access ProgramSM, you can call 1-800-477-6472.

• Stock Replacement Program
• Patient Eligibility
• Application Requirements
• Application Process

• Download AAP Overview Flashcard (PDF - 273 KB)